The store will not work correctly when cookies are disabled.
US8829190, 123
ID: ALA3676252
PubChem CID: 25115494
Max Phase: Preclinical
Molecular Formula: C18H16Br2N4O3
Molecular Weight: 496.16
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C(=O)Cc2c(Br)cncc2Br)n2nc(C3(CO)CC3)nc12
Standard InChI: InChI=1S/C18H16Br2N4O3/c1-27-15-3-2-13(14(26)6-10-11(19)7-21-8-12(10)20)24-16(15)22-17(23-24)18(9-25)4-5-18/h2-3,7-8,25H,4-6,9H2,1H3
Standard InChI Key: YDYODAPREUATFE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
3.6387 -0.8963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5973 1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6375 0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8934 5.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8542 5.8570 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-5.1924 6.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4915 5.2571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4915 3.7571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1925 3.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1925 1.8070 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.4133 -1.7530 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8032 -3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3114 -2.9665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5502 -4.4225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7978 -5.7212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3955 -6.7617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.7173 -3.6745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7147 -5.1745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 10 1 0
16 17 1 0
6 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 3 1 0
22 18 1 0
20 23 1 0
23 24 1 0
24 25 1 0
23 26 1 0
26 27 1 0
27 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 496.16 | Molecular Weight (Monoisotopic): 493.9589 | AlogP: 3.11 | #Rotatable Bonds: 6 |
Polar Surface Area: 89.61 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.07 | CX Basic pKa: 1.77 | CX LogP: 3.11 | CX LogD: 3.11 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.53 | Np Likeness Score: -0.31 |
References
1. (2014) Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases, |